Literature DB >> 1115842

Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism.

J Cade, J Hirsh, E Regoeczi.   

Abstract

The mechanism and significance of elevated levels of serum fibrin degradation products (FDP) in pulmonary embolism were investigated experimentally. Dogs were embolized with autologous blood clot-incorporating canine 125I-fibrin and were infused with either saline, heparin, or streptokinase. Serial measurements were made of total FDP by hemagglutination inhibition assay and of radioactive FDP. After saline, the peak level of total FDP was 323 mug/ml, but radioactive FDP was only 8 mug/ml. After heparin, these values were 44 and 11 mug/ml, respectively, and after streptokinase, 415 and 20 mug/ml. The results suggest that under these experimental conditions the elevated levels of FDP in pulmonary embolism are derived mainly from lysis of fibrin deposited after embolization rather than from lysis of the original embolus. Heparin inhibits both fibrin deposition and elevation of FDP levels after embolism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115842

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Plasma cross linked fibrin degradation products in pulmonary embolism.

Authors:  B J Rowbotham; J Egerton-Vernon; A N Whitaker; M J Elms; I H Bunce
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

2.  Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.

Authors:  M A Blajchman; A F Senyi; J Hirsh; Y Surya; M Buchanan; J F Mustard
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

3.  Pulmonary infarction, myocardial infarction, and acute disseminated intravascular coagulation.

Authors:  F J Thomson; E W Benbow; R F McMahon; C M Cheshire
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

4.  The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.

Authors:  H L Nossel; M Ti; K L Kaplan; K Spanondis; T Soland; V P Butler
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

5.  Pulmonary embolism as the initial manifestation of large cell lung cancer--a case report with review.

Authors:  J K Kim; S M Lee; H T Kim; S Uh; Y Chung; Y H Kim; C Park; S Y Jin; D H Lee
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.